Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Endocrinology

  • News

    Diabetic retinopathy may predict greater risk of COVID-19 severity

    December 3, 2020

    “Our study reports the first description of diabetic retinopathy as a potential risk factor for poor COVID-19 outcomes,” said the authors of a new study.

  • News

    Blood glucose on admission predicts COVID-19 severity in all

    November 30, 2020

    Those with abnormally high glucose levels were more than twice as likely to die from the virus than were those with normal readings.

  • News

    New eGFR equation ‘less biased’ by age, kidney function; some disagree

    November 10, 2020

    The European Kidney Function Consortium equation surpasses existing equations by "resulting in generally lower bias across the spectrum of age and kidney function," according to its developers.

  • 1
    News

    No link shown between thyroid dysfunction and heart failure

    November 10, 2020

    Analysis of nearly 5,000 English heart failure patients showed no significant link between thyroid dysfunction and survival.

  • News

    First-of-its kind guideline on lipid monitoring in endocrine diseases

    November 6, 2020

    A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond diabetes; the aim is to make lipid panel routine in assessment.

  • News

    Consensus guidelines address inpatient diabetes technology

    October 29, 2020

    The comprehensive document aimed at clinicians, hospitals, and researchers covers use of both continuous glucose monitors and automated insulin dosing systems in the hospital setting.

  • News

    Vertebral fractures in COVID-19 linked to mortality

    October 28, 2020

    Radiologic thoracic vertebral fractures were found in one-third of COVID-19 patients who underwent lateral chest x-rays, and those patients were twice as likely to die.

  • 1
    News

    No mortality benefit after intensive glucose control once Hb A1c curves equalize

    October 23, 2020

    Is there a reduction in cardiovascular events in veterans with type 2 diabetes who were treated with intensive glucose control versus standard therapy at 15 years’ follow-up?

  • News

    COVID-19 antibody response not reduced with diabetes

    October 20, 2020

    Findings provide “cautious optimism” that a COVID-19 vaccine would be expected to work as well in people with diabetes as those without.

  • News

    Entresto halves renal events in preserved EF heart failure patients

    October 15, 2020

    The PARAGON-HF trial of sacubitril/valsartan in patients with heart failure with preserved ejection fraction didn’t meet its primary outcome but significantly improved a secondary renal endpoint.

Previous1 … 4 5 6 7 8 … 18Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences